| Structure and function of the complex formed by the tuberculosis virulence factors CFP‐10 and ESAT‐6 PS Renshaw, KL Lightbody, V Veverka, FW Muskett, G Kelly, TA Frenkiel, ... The EMBO journal 24 (14), 2491-2498, 2005 | 444 | 2005 |
| Structure and interactions of the human programmed cell death 1 receptor X Cheng, V Veverka, A Radhakrishnan, LC Waters, FW Muskett, ... Journal of Biological Chemistry 288 (17), 11771-11785, 2013 | 419 | 2013 |
| Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein DC Dinesh, D Chalupska, J Silhan, E Koutna, R Nencka, V Veverka, ... PLoS pathogens 16 (12), e1009100, 2020 | 327 | 2020 |
| Characterization of the structural features and interactions of sclerostin V Veverka, AJ Henry, PM Slocombe, A Ventom, B Mulloy, FW Muskett, ... Journal of Biological Chemistry 284 (16), 10890-10900, 2009 | 307 | 2009 |
| Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers HC Hodges, BZ Stanton, K Cermakova, CY Chang, EL Miller, JG Kirkland, ... Nature structural & molecular biology 25 (1), 61-72, 2018 | 205 | 2018 |
| PI(4,5)P2 controls plasma membrane PI4P and PS levels via ORP5/8 recruitment to ER–PM contact sites M Sohn, M Korzeniowski, JP Zewe, RC Wills, GRV Hammond, ... Journal of Cell Biology 217 (5), 1797-1813, 2018 | 203 | 2018 |
| Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small … V Veverka, T Crabbe, I Bird, G Lennie, FW Muskett, RJ Taylor, MD Carr Oncogene 27 (5), 585-595, 2008 | 193 | 2008 |
| Calcium-driven folding of RTX domain β-rolls ratchets translocation of RTX proteins through type I secretion ducts L Bumba, J Masin, P Macek, T Wald, L Motlova, I Bibova, N Klimova, ... Molecular cell 62 (1), 47-62, 2016 | 182 | 2016 |
| Solution structure of the Mycobacterium tuberculosis EsxG· EsxH complex: functional implications and comparisons with other M. tuberculosis Esx family complexes D Ilghari, KL Lightbody, V Veverka, LC Waters, FW Muskett, PS Renshaw, ... Journal of Biological Chemistry 286 (34), 29993-30002, 2011 | 133 | 2011 |
| Structural insights and in vitro reconstitution of membrane targeting and activation of human PI4KB by the ACBD3 protein M Klima, DJ Tóth, R Hexnerova, A Baumlova, D Chalupska, J Tykvart, ... Scientific reports 6 (1), 23641, 2016 | 105 | 2016 |
| Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors G Holdsworth, P Slocombe, C Doyle, B Sweeney, V Veverka, K Le Riche, ... Journal of Biological Chemistry 287 (32), 26464-26477, 2012 | 104 | 2012 |
| Structural diversity in p160/CREB-binding protein coactivator complexes L Waters, B Yue, V Veverka, P Renshaw, J Bramham, S Matsuda, ... Journal of Biological Chemistry 281 (21), 14787-14795, 2006 | 86 | 2006 |
| Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif P Tesina, K Čermáková, M Hořejší, K Procházková, M Fábry, S Sharma, ... Nature communications 6 (1), 7968, 2015 | 77 | 2015 |
| Human DNA-damage-inducible 2 protein is structurally and functionally distinct from its yeast ortholog M Sivá, M Svoboda, V Veverka, JF Trempe, K Hofmann, M Kožíšek, ... Scientific reports 6 (1), 30443, 2016 | 76 | 2016 |
| A ubiquitous disordered protein interaction module orchestrates transcription elongation K Cermakova, J Demeulemeester, V Lux, M Nedomova, SR Goldman, ... Science 374 (6571), 1113-1121, 2021 | 72 | 2021 |
| Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A LC Waters, V Veverka, M Böhm, T Schmedt, PT Choong, FW Muskett, ... Oncogene 26 (34), 4941-4950, 2007 | 71 | 2007 |
| High Resolution NMR-based Model for the Structure of a scFv-IL-1β Complex IC Wilkinson, CJ Hall, V Veverka, JY Shi, FW Muskett, PE Stephens, ... Journal of Biological Chemistry 284 (46), 31928-31935, 2009 | 69 | 2009 |
| Characterization of three druggable hot-spots in the Aurora-A/TPX2 interaction using biochemical, biophysical, and fragment-based approaches PJ McIntyre, PM Collins, L Vrzal, K Birchall, LH Arnold, C Mpamhanga, ... ACS chemical biology 12 (11), 2906-2914, 2017 | 65 | 2017 |
| Validation and structural characterization of the LEDGF/p75–MLL interface as a new target for the treatment of MLL-dependent leukemia K Čermáková, P Tesina, J Demeulemeester, S El Ashkar, H Mereau, ... Cancer research 74 (18), 5139-5151, 2014 | 65 | 2014 |
| Forkhead domains of FOXO transcription factors differ in both overall conformation and dynamics K Psenakova, K Kohoutova, V Obsilova, MJ Ausserlechner, V Veverka, ... Cells 8 (9), 966, 2019 | 63 | 2019 |
Alistair J. HenryUCBVerified email at ucb.com
